Else M�ller-Schweinitzer

601 total citations
15 papers, 498 citations indexed

About

Else M�ller-Schweinitzer is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Else M�ller-Schweinitzer has authored 15 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Pharmacology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Else M�ller-Schweinitzer's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Pharmacology and Obesity Treatment (3 papers). Else M�ller-Schweinitzer is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers) and Pharmacology and Obesity Treatment (3 papers). Else M�ller-Schweinitzer collaborates with scholars based in Germany and Japan. Else M�ller-Schweinitzer's co-authors include P. A. Stadler, M. G�thert, Lea Sistonen, G. Engel, Eberhard Schlicker, Jos� M. Palacios, Carlo Tapparelli and Peter Ellis and has published in prestigious journals such as Naunyn-Schmiedeberg s Archives of Pharmacology and European Journal of Clinical Pharmacology.

In The Last Decade

Else M�ller-Schweinitzer

15 papers receiving 405 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Else M�ller-Schweinitzer Germany 11 256 242 113 66 63 15 498
Pramod R. Saxena Netherlands 13 188 0.7× 217 0.9× 151 1.3× 83 1.3× 205 3.3× 18 521
Howard S. Blaxall United States 11 324 1.3× 368 1.5× 104 0.9× 26 0.4× 35 0.6× 13 584
P. R. Saxena Netherlands 9 152 0.6× 134 0.6× 138 1.2× 158 2.4× 79 1.3× 18 461
L. Cubeddu United States 12 267 1.0× 360 1.5× 124 1.1× 22 0.3× 57 0.9× 15 587
T A Branchek United States 7 464 1.8× 514 2.1× 127 1.1× 81 1.2× 34 0.5× 7 833
L. J. Bryan‐Lluka Australia 15 287 1.1× 276 1.1× 78 0.7× 48 0.7× 26 0.4× 38 614
Alberto Meli Italy 12 297 1.2× 186 0.8× 198 1.8× 28 0.4× 29 0.5× 16 601
David Pollock United Kingdom 10 245 1.0× 254 1.0× 244 2.2× 19 0.3× 75 1.2× 27 566
Farnebo Lo Sweden 12 212 0.8× 249 1.0× 52 0.5× 20 0.3× 47 0.7× 23 561
Hugh H. Dalziel United States 11 236 0.9× 268 1.1× 353 3.1× 29 0.4× 98 1.6× 13 731

Countries citing papers authored by Else M�ller-Schweinitzer

Since Specialization
Citations

This map shows the geographic impact of Else M�ller-Schweinitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Else M�ller-Schweinitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Else M�ller-Schweinitzer more than expected).

Fields of papers citing papers by Else M�ller-Schweinitzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Else M�ller-Schweinitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Else M�ller-Schweinitzer. The network helps show where Else M�ller-Schweinitzer may publish in the future.

Co-authorship network of co-authors of Else M�ller-Schweinitzer

This figure shows the co-authorship network connecting the top 25 collaborators of Else M�ller-Schweinitzer. A scholar is included among the top collaborators of Else M�ller-Schweinitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Else M�ller-Schweinitzer. Else M�ller-Schweinitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
M�ller-Schweinitzer, Else, et al.. (1993). Heterogeneity of 5-HT receptor subtypes in isolated human femoral and saphenous veins. Naunyn-Schmiedeberg s Archives of Pharmacology. 347(2). 133–6. 7 indexed citations
2.
M�ller-Schweinitzer, Else & Peter Ellis. (1992). Sucrose promotes the functional activity of blood vessels after cryopreservation in DMSO-containing fetal calf serum. Naunyn-Schmiedeberg s Archives of Pharmacology. 345(5). 594–7. 14 indexed citations
3.
M�ller-Schweinitzer, Else. (1989). Interaction of cyclosporine-A with the renin-angiotensin system in canine veins. Naunyn-Schmiedeberg s Archives of Pharmacology. 340(2). 252–7. 9 indexed citations
4.
M�ller-Schweinitzer, Else. (1988). Changes in the venous compliance by bradykinin and angiotensin II and its significance for the vascular effects of cyclosporine-A. Naunyn-Schmiedeberg s Archives of Pharmacology. 338(6). 699–703. 16 indexed citations
5.
M�ller-Schweinitzer, Else & Carlo Tapparelli. (1986). Pharmacological studies on frozen stored canine saphenous veins and basilar arteries. Naunyn-Schmiedeberg s Archives of Pharmacology. 332(1). 74–78. 22 indexed citations
6.
M�ller-Schweinitzer, Else. (1984). Alpha-adrenoceptors, 5-hydroxytryptamine receptors and the action of dihydroergotamine in human venous preparations obtained during saphenectomy procedures for varicose veins. Naunyn-Schmiedeberg s Archives of Pharmacology. 327(4). 299–303. 29 indexed citations
7.
M�ller-Schweinitzer, Else. (1984). Pharmacological actions of the main metabolites of dihydroergotamine. European Journal of Clinical Pharmacology. 26(6). 699–705. 39 indexed citations
8.
M�ller-Schweinitzer, Else, et al.. (1984). 2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 325(4). 328–336. 61 indexed citations
9.
M�ller-Schweinitzer, Else. (1983). Tissue specific susceptibility of alpha-adrenoceptor mediated vasoconstriction to nifedipine. Naunyn-Schmiedeberg s Archives of Pharmacology. 324(1). 64–69. 28 indexed citations
10.
M�ller-Schweinitzer, Else, et al.. (1983). Evidence for mediation by 5-HT2 receptors of 5-hydroxytryptamine-induced contraction of canine basilar artery. Naunyn-Schmiedeberg s Archives of Pharmacology. 324(4). 287–292. 54 indexed citations
11.
Engel, G., M. G�thert, Else M�ller-Schweinitzer, et al.. (1983). Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves. Naunyn-Schmiedeberg s Archives of Pharmacology. 324(2). 116–124. 162 indexed citations
12.
M�ller-Schweinitzer, Else. (1982). Actions of Co-Dergocrine mesylate and its components at vascular smooth muscle. Naunyn-Schmiedeberg s Archives of Pharmacology. 318(3). 225–233. 10 indexed citations
13.
M�ller-Schweinitzer, Else. (1976). Evidence for stimulation of 5-HT receptors in canine saphenous arteries by ergotamine. Naunyn-Schmiedeberg s Archives of Pharmacology. 295(1). 41–44. 16 indexed citations
14.
M�ller-Schweinitzer, Else. (1976). Responsiveness of isolated canine cerebral and peripheral arteries to ergotamine. Naunyn-Schmiedeberg s Archives of Pharmacology. 292(2). 113–118. 25 indexed citations
15.
M�ller-Schweinitzer, Else, et al.. (1973). In vitro demonstration of the existence of ?-adrenoceptors in human saphenous and canine femoral veins. Naunyn-Schmiedeberg s Archives of Pharmacology. 280(2). 153–160. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pramod R. Saxena Breakdown of academic impact, for papers by Howard S. Blaxall Breakdown of academic impact, for papers by P. R. Saxena Breakdown of academic impact, for papers by L. Cubeddu Breakdown of academic impact, for papers by T A Branchek Breakdown of academic impact, for papers by L. J. Bryan‐Lluka Breakdown of academic impact, for papers by Alberto Meli Breakdown of academic impact, for papers by David Pollock Breakdown of academic impact, for papers by Farnebo Lo Breakdown of academic impact, for papers by Hugh H. Dalziel
Rankless by CCL
2026